One-Year Results of Treatment of Diabetic Macular Edema with Aflibercept Using the Treat-and-Extend Dosing Regimen: the VIBIM Study | Zendy

Kang Yeun Pak | Zendy; Jae Pil Shin | Zendy; Hyun Woong Kim | Zendy; Min Sagong | Zendy; Yu Cheol Kim | Zendy; Sang Joon Lee | Zendy; In Young Chung | Zendy; Sung Who Park | Zendy; Ji Eun Lee | Zendy

Open Access

One-Year Results of Treatment of Diabetic Macular Edema with Aflibercept Using the Treat-and-Extend Dosing Regimen: the VIBIM Study

Author(s) -

Kang Yeun Pak,

Jae Pil Shin,

Hyun Woong Kim,

Min Sagong,

Yu Cheol Kim,

Sang Joon Lee,

In Young Chung,

Sung Who Park,

Ji Eun Lee

Publication year - 2020

Publication title -

ophthalmologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.639

H-Index - 60

eISSN - 1423-0267

pISSN - 0030-3755

DOI - 10.1159/000504753

Subject(s) - aflibercept , medicine , diabetic macular edema , regimen , visual acuity , confidence interval , ophthalmology , macular edema , dosing , prospective cohort study , edema , diabetic retinopathy , surgery , diabetes mellitus , bevacizumab , chemotherapy , endocrinology

The purpose of this study was to report the one-year results of treatment of diabetic macular edema (DME) with aflibercept using a treat-and-extend regimen (TER).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research